688 related articles for article (PubMed ID: 10433700)
1. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
2. Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime.
Luo C; Saxena A; Ashani Y; Leader H; Radić Z; Taylor P; Doctor BP
Chem Biol Interact; 1999 May; 119-120():129-35. PubMed ID: 10421446
[TBL] [Abstract][Full Text] [Related]
3. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
5. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
6. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands.
Luo C; Ashani Y; Doctor BP
Mol Pharmacol; 1998 Apr; 53(4):718-26. PubMed ID: 9547363
[TBL] [Abstract][Full Text] [Related]
9. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
10. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
12. Kinetic prerequisites of oximes as effective reactivators of organophosphate-inhibited acetylcholinesterase: a theoretical approach.
Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):303-8. PubMed ID: 20807085
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
14. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
Luo C; Chambers C; Yang Y; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):185-90. PubMed ID: 20096273
[TBL] [Abstract][Full Text] [Related]
15. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
16. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
17. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
[TBL] [Abstract][Full Text] [Related]
18. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
Hanke DW; Overton MA
J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
[TBL] [Abstract][Full Text] [Related]
19. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]